BioWorld MedTech

June 27, 2016

Resistant superbug s arrival highlights the need for more effective diagnostic products

Politicians and medical experts worldwide alike have decried the lack of innovation in antibiotics an area that has been neglected for three decades but another area is turning out to be just as important: diagnostics. Read More

Cut the blame game, infection control is a shared problem

What s inside your IV catheter?

Med-tech industry tries to find footing in wake of affirmative Brexit vote

FDA informs Franken MDRs offer no news on Medtronic s Infuse

South Korea cautiously considering 3-D printed medical instruments

Other news to note

Product briefs

MDD's Company Stock Report

Appointments and advancements

Neurology Extra

Rapid point-of-care tests for anti-microbial resistance

Today's news in brief

BioWorld

BioWorld briefs for Dec. 19, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 19, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.